GO:0032365 intracellular lipid transport: Cellular Lipid Trafficking, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032365 intracellular lipid transport is defined as the directed movement of lipids within cells, a process essential for membrane biogenesis, energy homeostasis, and signaling.
• Cholesterol and other lipids move between organelles via vesicular and non-vesicular mechanisms, often at membrane contact sites such as lysosome-peroxisome and mitochondria-ER junctions.
• Key proteins include NPC1, STARD4, and components of the mTOR pathway, which regulate lipid uptake, transport, and storage.
• Defects in intracellular lipid transport underlie diseases such as Niemann-Pick type C, atherosclerosis, and neurodegeneration.
• CRISPR-based models (knockout, knock-in, point mutation) enable precise dissection of lipid transport genes in human cells.
• Studying this process requires a combination of imaging, lipidomics, and genetic screens to track lipid movement and organelle contacts.
Description
Intracellular lipid transport (GO:0032365) encompasses the directed movement of lipids within cells, a fundamental process that ensures proper distribution of cholesterol, phospholipids, sphingolipids, and other lipid species to their target organelles. Lipids are not merely structural components; they serve as signaling molecules, energy stores, and organizers of membrane microdomains. Their intracellular trafficking is therefore critical for cellular homeostasis, and its disruption is linked to a wide range of pathologies. Research into this process has revealed that lipids move via both vesicular and non-vesicular pathways, often at membrane contact sites where organelles come into close apposition. For example, cholesterol transport from lysosomes to peroxisomes occurs at lysosome-peroxisome membrane contacts, a process dependent on NPC1. Similarly, mitochondrial cholesterol import is mediated by specialized transport machinery. Understanding these mechanisms is essential for developing therapies for lipid storage disorders, cardiovascular diseases, and neurodegenerative conditions. This article provides a comprehensive overview of GO:0032365, covering its definition, molecular players, regulatory mechanisms, disease relevance, and the CRISPR-based tools available to study it.
intracellular lipid transport At A Glance
| GO ID | GO:0032365 |
|---|---|
| GO term | intracellular lipid transport |
| Ontology | biological_process |
| Synonym | none |
| Major function | Directed movement of lipids within cells, including cholesterol, phospholipids, and sphingolipids |
| Related processes | Membrane contact site-mediated transport, vesicular trafficking, lipid droplet dynamics |
| Key proteins | NPC1, STARD4, mTOR, lysosomal and peroxisomal proteins |
| Disease relevance | Niemann-Pick type C, atherosclerosis, neurodegeneration, cancer |
What Is GO:0032365?
According to the Gene Ontology, intracellular lipid transport (GO:0032365) is the directed movement of lipids within cells. This includes the translocation of lipid molecules between organelles, such as from the plasma membrane to the endoplasmic reticulum, from lysosomes to peroxisomes, or from the ER to mitochondria. The process can occur via vesicular carriers or through non-vesicular mechanisms involving lipid transfer proteins at membrane contact sites.
Why Is intracellular lipid transport Important in Cell Biology?
Intracellular lipid transport is vital for maintaining cellular lipid homeostasis, and its dysregulation is a hallmark of numerous diseases. For instance, mutations in NPC1, a key cholesterol transporter, cause Niemann-Pick type C disease, a fatal neurodegenerative disorder. Additionally, mTOR inhibition reprograms lipid homeostasis by inducing alternative lipid uptake and promoting cholesterol transport, highlighting the interplay between signaling pathways and lipid trafficking. Understanding GO:0032365 is therefore crucial for uncovering disease mechanisms and identifying therapeutic targets.
• Maintains membrane lipid asymmetry and organelle identity.
• Regulates cholesterol distribution and prevents toxic accumulation.
• Supports energy metabolism by delivering fatty acids to mitochondria.
• Facilitates autophagic membrane expansion and lysosomal function.
• Modulates cell signaling by controlling lipid second messengers.
• Influences viral entry, as seen with Ebola virus requiring NPC1.
• Implicated in cancer progression through altered lipid metabolism.
• Contributes to neurodegeneration when impaired, as in Niemann-Pick type C.
• Provides targets for pharmacological intervention in lipid disorders.
• Essential for axonal transport and neuronal survival.
What Happens During intracellular lipid transport?
Lipid Uptake and Endosomal Sorting
In simple terms: Cells take in lipids from outside and sort them into the right compartments.
Lipids enter cells via endocytosis or direct uptake and are delivered to endosomes and lysosomes. From there, they are sorted to various organelles. For example, cholesterol uptake is mediated by LDL receptor and delivered to lysosomes, where NPC1 facilitates its export. mTOR inhibition can induce alternative lipid uptake pathways, altering the cellular lipid landscape.
Non-vesicular Transport at Membrane Contact Sites
In simple terms: Lipids can hop between organelles at points where membranes touch.
Membrane contact sites (MCSs) are specialized regions where two organelles are closely apposed, allowing direct lipid transfer. The lysosome-peroxisome contact site is a prime example, where cholesterol is transported from lysosomes to peroxisomes in an NPC1-dependent manner. Similarly, mitochondria-associated membranes (MAMs) facilitate cholesterol import into mitochondria.
Vesicular Trafficking of Lipids
In simple terms: Lipids can also be carried inside small vesicles that bud off and fuse with other organelles.
Vesicular transport involves the packaging of lipids into membrane-bound carriers that move along cytoskeletal tracks. This pathway is particularly important for delivering lipids to the plasma membrane and for maintaining lipid droplet dynamics. Defects in vesicular trafficking can lead to lipid accumulation and cellular stress.
Lipid Droplet Formation and Turnover
In simple terms: Excess lipids are stored in fat droplets and later released when needed.
Lipid droplets are organelles that store neutral lipids, such as triglycerides and cholesterol esters. Their formation and breakdown are tightly linked to intracellular lipid transport. Proteins like STARD4 are involved in sterol transport to lipid droplets and other organelles. Dysregulation of lipid droplet dynamics contributes to metabolic diseases.
Regulation by Signaling Pathways
In simple terms: Cellular signals tell the cell when to move lipids around.
The mTOR pathway is a master regulator of lipid metabolism. Inhibition of mTOR reprograms lipid homeostasis by promoting cholesterol transport and alternative lipid uptake. Other signaling pathways, such as those involving sterol regulatory element-binding proteins (SREBPs), also modulate lipid transport gene expression.
Key Genes Involved in GO:0032365 intracellular lipid transport
The following genes and proteins are central to intracellular lipid transport (GO:0032365), as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NPC1 | Cholesterol transport from lysosomes to other organelles | Mutations cause Niemann-Pick type C; target for Ebola virus entry |
| STARD4 | Non-vesicular sterol transport | Regulates cholesterol distribution; linked to lipid metabolism |
| mTOR | Signaling hub regulating lipid homeostasis | Inhibition alters lipid uptake and transport |
| NPC2 | Cholesterol binding and transfer in lysosomes | Works with NPC1 in cholesterol export |
| OSBP | Cholesterol and phosphatidylinositol 4-phosphate transfer at MCS | Implicated in membrane contact site function |
| VAPB | Membrane contact site tethering | Facilitates ER-mitochondria lipid transfer |
| PEX proteins | Peroxisome biogenesis and function | Required for lysosome-peroxisome contacts |
| Rab7 | Endosomal trafficking | Regulates lysosome positioning and lipid transport |
| LAMP1 | Lysosomal membrane protein | Marker for lysosomal lipid transport studies |
| SNX proteins | Sorting nexins in endosomal trafficking | Involved in lipid sorting and transport |
| ABCA1 | Cholesterol efflux | Affects intracellular cholesterol pools |
| SREBP2 | Cholesterol sensing transcription factor | Regulates expression of lipid transport genes |
| Caveolin-1 | Lipid raft and cholesterol transport | Role in cholesterol trafficking |
| Flotillin | Lipid raft-associated protein | Implicated in endosomal lipid sorting |
| ORP family | Oxysterol-binding protein-related proteins | Non-vesicular lipid transfer at MCS |
| CERT | Ceramide transfer protein | Transports ceramide from ER to Golgi |
| FAPP2 | Glycolipid transfer protein | Involved in glycosphingolipid transport |
How Is intracellular lipid transport Regulated?
Intracellular lipid transport is regulated at multiple levels. The mTOR signaling pathway plays a central role; its inhibition leads to reprogramming of lipid homeostasis, including increased cholesterol transport and alternative lipid uptake. Sterol levels are sensed by SREBP2, which controls the expression of genes involved in cholesterol uptake and synthesis. Additionally, membrane contact sites are dynamically regulated by tethering proteins such as VAPB and OSBP, which respond to lipid signals and calcium. Post-translational modifications of transport proteins, such as phosphorylation, also modulate their activity.
intracellular lipid transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NPC1 | Niemann-Pick type C | NPC1 knockout HeLa cells; patient-derived fibroblasts |
| STARD4 | Cholesterol metabolism disorders | STARD4 knockout HepG2 cells |
| mTOR | Cancer, metabolic syndrome | mTOR knockout or knockdown in cancer cell lines |
| NPC2 | Niemann-Pick type C | NPC2 knockout macrophages |
| VAPB | Amyotrophic lateral sclerosis | VAPB mutant motor neurons |
Niemann-Pick Type C Disease
Niemann-Pick type C (NPC) is a fatal neurodegenerative disorder caused by mutations in NPC1 or NPC2, leading to defective cholesterol transport from lysosomes. This results in cholesterol accumulation in lysosomes and impaired autophagic flux, contributing to neuronal dystrophy. Studies in NPC models have revealed that lipid-mediated motor-adaptor sequestration impairs axonal lysosome delivery, leading to autophagic stress.
Metabolic Disorders and Cancer
Altered intracellular lipid transport is a hallmark of metabolic diseases such as atherosclerosis and fatty liver disease. In cancer, reprogramming of lipid metabolism supports rapid proliferation and survival. mTOR inhibition, which reprograms lipid homeostasis, is being explored as a therapeutic strategy. Cholesterol transport proteins like STARD4 are potential targets for modulating lipid availability in cancer cells.
Neurodegeneration
Defects in lipid transport contribute to neurodegenerative diseases beyond NPC, including Alzheimer's and Parkinson's. Proper axonal transport of lipids is essential for neuronal function, and its disruption leads to synaptic dysfunction and neuronal death. Mitochondrial cholesterol import defects can also impair energy metabolism in neurons.
From intracellular lipid transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NPC1 impair cholesterol transport? | NPC1 knockout cell line (e.g., HeLa) |
| How does a point mutation in STARD4 affect sterol binding? | STARD4 point-mutant knock-in cells |
| Can overexpression of mTOR rescue lipid transport defects? | mTOR overexpression in patient fibroblasts |
| Where does NPC1 localize in live cells? | NPC1-GFP knock-in cells |
| What genes regulate lysosome-peroxisome contacts? | CRISPR library screening in HeLa cells |
| Does mutant VAPB disrupt ER-mitochondria lipid transfer? | VAPB knockout or mutant neurons |
How to Study the intracellular lipid transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Localization and movement of fluorescent lipids | Tracking cholesterol transport in live cells |
| Lipidomics (LC-MS) | Lipid species abundance and composition | Quantifying changes in lipid pools after gene knockout |
| CRISPR knockout screen | Genes required for lipid transport | Identifying novel regulators of cholesterol trafficking |
| FRET-based lipid transfer assay | Real-time lipid transfer between membranes | Measuring STARD4 activity in vitro |
| Electron microscopy | Ultrastructure of membrane contact sites | Visualizing lysosome-peroxisome contacts |
| Proteomics | Protein interactions and complexes | Identifying NPC1 interactors |
| RNA-seq | Transcriptional changes in lipid transport genes | Assessing SREBP2 target gene expression |
| Nanomechanical action | Endo-lysosomal membrane permeabilization | Studying lipid transport after organelle disruption |
Imaging Lipid Transport
Fluorescent lipid analogs (e.g., BODIPY-cholesterol) and genetically encoded sensors allow real-time visualization of lipid movement. Live-cell imaging combined with organelle markers reveals transport pathways and contact sites. Super-resolution microscopy can resolve nanoscale membrane contacts.
Lipidomics and Mass Spectrometry
Mass spectrometry-based lipidomics quantifies lipid species and their distribution across organelles. This approach can identify changes in lipid composition upon genetic perturbation or drug treatment.
Genetic Screens
CRISPR knockout libraries enable unbiased discovery of genes required for intracellular lipid transport. For example, a genome-wide screen identified factors needed for lysosome-peroxisome cholesterol transport. Such screens can be coupled with lipid reporters or phenotypic readouts.
Biochemical Assays
In vitro assays using purified proteins and liposomes measure lipid transfer activity. For instance, STARD4-mediated sterol transfer can be monitored by fluorescence resonance energy transfer (FRET). Membrane contact site reconstitution assays help dissect tethering and transfer mechanisms.
How CRISPR Can Be Used to Study GO:0032365 intracellular lipid transport
Knockout
CRISPR knockout of genes such as NPC1, STARD4, or mTOR allows researchers to assess their necessity in intracellular lipid transport. For example, NPC1 knockout cells accumulate cholesterol in lysosomes, mimicking Niemann-Pick type C. Knockout models are invaluable for identifying essential components and for drug screening.
Point Mutation
Introducing disease-associated point mutations (e.g., NPC1 mutations found in patients) via CRISPR base editing or homology-directed repair enables study of specific functional defects. Such models can reveal how single amino acid changes affect lipid binding or transport activity.
Knock-in
Knock-in of tagged versions of lipid transport proteins (e.g., NPC1-GFP) facilitates live-cell imaging and proteomic analysis. This approach preserves endogenous regulation and localization, providing insights into dynamic transport processes.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can elevate levels of transport proteins to study gain-of-function effects. Overexpression of mTOR, for instance, can alter lipid homeostasis and transport. This is useful for testing whether increased transport activity can rescue disease phenotypes.
How EDITGENE Supports intracellular lipid transport Research
Researchers studying intracellular lipid transport-related genes often need to determine whether a candidate gene is causally involved in lipid trafficking, and to dissect its precise function using genetically defined models. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for intracellular lipid transport research.
Frequently Asked Questions About intracellular lipid transport
What is intracellular lipid transport (GO:0032365)?
It is the directed movement of lipids within cells, including cholesterol, phospholipids, and sphingolipids, as defined by the Gene Ontology.
What genes are involved in intracellular lipid transport?
Key genes include NPC1, STARD4, mTOR, NPC2, OSBP, VAPB, and many others that mediate lipid transfer between organelles.
How does cholesterol move inside cells?
Cholesterol moves via vesicular and non-vesicular pathways, often at membrane contact sites such as lysosome-peroxisome and mitochondria-ER junctions.
What diseases are linked to defective intracellular lipid transport?
Niemann-Pick type C, atherosclerosis, neurodegeneration, and cancer are associated with defects in lipid transport.
What is the role of NPC1 in lipid transport?
NPC1 is a lysosomal cholesterol transporter essential for exporting cholesterol from lysosomes; mutations cause Niemann-Pick type C.
How can I study intracellular lipid transport using CRISPR?
CRISPR knockout, knock-in, point mutation, and overexpression models allow functional dissection of lipid transport genes.
What methods are used to measure intracellular lipid transport?
Fluorescence imaging, lipidomics, FRET assays, and genetic screens are commonly used.
Is mTOR involved in lipid transport?
Yes, mTOR signaling regulates lipid homeostasis, and its inhibition reprograms lipid uptake and cholesterol transport.
What are membrane contact sites in lipid transport?
They are regions where organelles are closely apposed, enabling direct lipid transfer without vesicles.
Can I order custom CRISPR models for lipid transport genes?
Yes, EDITGENE provides knockout, point mutation, knock-in, and overexpression models for any lipid transport gene.
Conclusion
Intracellular lipid transport (GO:0032365) is a fundamental cellular process that ensures proper lipid distribution and homeostasis. Its dysregulation contributes to a spectrum of diseases, from Niemann-Pick type C to cancer and neurodegeneration. Advances in CRISPR-based models and imaging technologies are rapidly expanding our understanding of the molecular players and regulatory mechanisms involved. EDITGENE offers a comprehensive toolkit to study these processes, empowering researchers to uncover new therapeutic targets.
References
- 1. Shin S et al.. 2025. mTOR inhibition reprograms cellular lipid homeostasis by inducing alternative lipid uptake and promoting cholesterol transport.. Mol Cell 85(18):3486-3504.e7 PMID: 40972529
- 2. Chu BB et al.. 2015. Cholesterol transport through lysosome-peroxisome membrane contacts.. Cell 161(2):291-306 PMID: 25860611
- 3. Elustondo P et al.. 2017. Mitochondrial cholesterol import.. Biochim Biophys Acta Mol Cell Biol Lipids 1862(1):90-101 PMID: 27565112
- 4. Roney JC et al.. 2021. Lipid-mediated motor-adaptor sequestration impairs axonal lysosome delivery leading to autophagic stress and dystrophy in Niemann-Pick type C.. Dev Cell 56(10):1452-1468.e8 PMID: 33878344
- 5. Zhao Y et al.. 2023. Nanomechanical action opens endo-lysosomal compartments.. Nat Commun 14(1):6645 PMID: 37863882
- 6. Maxfield FR et al.. 2016. Role of STARD4 and NPC1 in intracellular sterol transport.. Biochem Cell Biol 94(6):499-506 PMID: 27421092
- 8. Carette JE et al.. 2011. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1.. Nature 477(7364):340-3 PMID: 21866103
